Skip to main content

Advertisement

SpringerLink
Log in

Biodegradable Ocular Inserts for Sustained Delivery of Brimonidine Tartarate: Preparation and In Vitro/In Vivo Evaluation

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The bioavailability of therapeutic agents from eye drops is usually limited due to corneal barrier functions and effective eye protective mechanisms. Therefore, the current study aims to enhance ocular bioavailability of brimonidine, a potent antiglaucoma drug, through the preparation of ocular inserts. Solvent casting technique was employed to prepare the inserts using polyvinylpyrrolidone K-90 (PVP K-90) as film-forming polymer blended with different viscosity grades of bioadhesive polymers namely hydroxypropyl methycellulose, carbopol, sodium alginate, and chitosan. The prepared ocular inserts were evaluated for various physicochemical parameters, swelling behavior, and in vitro release patterns. Sodium alginate-based ocular inserts revealed the most sustainment in drug release (99% at 6 h), so it was selected for further modifications via coating it, on one side or dual sides, using hydrophobic film composed of either ethylcellulose or Eudragit RSPO. The obtained in vitro release results for the modified ocular inserts revealed that ethylcellulose is superior to Eudragit RSPO in terms of brimonidine release sustainment effect. Ocular inserts composed of 7% PVP K-90, 1.5% low molecular weight sodium alginate with or without ethylcellulose coat were able to sustain the in vitro release of brimonidine. Their therapeutic efficacy regarding intraocular pressure (IOP) lowering effect when inserted in albino rabbits eyes showed superior sustainment effect compared with that of brimonidine solution. Furthermore, due to both the mucoadhesive property and the drug sustainment effect, the one-side-coated ocular insert showed more IOP lowering effect compared with that of its non-coated or dual-side-coated counterpart.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Mundada AS, Shrikhande BK. Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride. Drug Dev Ind Pharm. 2006;32(4):443–8.

    Article  PubMed  CAS  Google Scholar 

  2. Ali Y, Lehmussaari K. Industrial perspective in ocular drug delivery. Adv Drug Deliv Rev. 2006;58(11):1258–68.

    Article  PubMed  CAS  Google Scholar 

  3. Wilson CG, Zhu YP, Frier M, Rao LS, Gilchrist P, Perkins AC. Ocular contact time of a carbomer gel (GelTears) in humans. Br J Ophthalmol. 1998;82(10):1131–4.

    Article  PubMed  CAS  Google Scholar 

  4. Wei G, Xu H, Ding PT, Li SM, Zheng JM. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. J Control Release. 2002;83(1):65–74.

    Article  PubMed  CAS  Google Scholar 

  5. Lee VH, Robinson JR. Topical ocular drug delivery: recent developments and future challenges. J Ocul Pharmacol. 1986;2(1):67–108.

    Article  PubMed  CAS  Google Scholar 

  6. Arici MK, Arici DS, Topalkara A, Guler C. Adverse effects of topical antiglaucoma drugs on the ocular surface. Clin Exp Ophthalmol. 2000;28(2):113–7.

    Article  CAS  Google Scholar 

  7. Gurtler F, Kaltsatos V, Boisrame B, Gumy R. Long-acting soluble bioadhesive ophthalmic drug insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigation. J Control Release. 1995;33:231–6.

    Article  CAS  Google Scholar 

  8. Hornof M, Weyenberg W, Ludwig A, Bernkop-Schnurch A. Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. J Control Release. 2003;89(3):419–28.

    Article  PubMed  CAS  Google Scholar 

  9. Malhotra M, Majumdar DK. Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: a technical note. AAPS PharmSciTech. 2006;7(4):96.

    Article  PubMed  Google Scholar 

  10. Sintzel M, Bernatchez S, Tabatabay C, Gurny R. Biomaterials in ophthalmic drug delivery. J Pharm Biopharm. 1996;42:258–374.

    Google Scholar 

  11. Qi H, Chen W, Huang C, Li L, Chen C, Li W, et al. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm. 2007;337(1–2):178–87.

    Article  PubMed  CAS  Google Scholar 

  12. Saettone MF, Salminen L. Ocular inserts for topical delivery. Adv Drug Deliv Rev. 1995;16:95–106.

    Article  CAS  Google Scholar 

  13. Koelwel C, Rothschenk S, Fuchs-Koelwel B, Gabler B, Lohmann C, Gopferich A. Alginate inserts loaded with epidermal growth factor for the treatment of keratoconjunctivitis sicca. Pharm Dev Technol. 2008;13(3):221–31.

    Article  PubMed  CAS  Google Scholar 

  14. Deshpande PB, Dandagi P, Udupa N, Gopal SV, Jain SS, Vasanth SG. Controlled release polymeric ocular delivery of acyclovir. Pharm Dev Technol. 2010;15(4):369–78.

    Article  PubMed  CAS  Google Scholar 

  15. Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844–51.

    PubMed  Google Scholar 

  16. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–7.

    Article  PubMed  CAS  Google Scholar 

  17. De TK, Rodman DJ, Holm BA, Prasad PN, Bergey EJ. Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery. J Microencapsul. 2003;20(3):361–74.

    PubMed  CAS  Google Scholar 

  18. Burke J, Manlapaz C, Kharlamb A, Runde E, Padillo E, Spada C, et al. Therapeutic use of α2-adrenoceptor agonists in glaucoma. In: Lanier S, Limbird L, editors. α2-Adrenergic receptors: structure, function and therapeutic implications. Reading: Harwood Academic Publishers; 1996. p. 179–87.

    Google Scholar 

  19. Munk SA, Harcourt D, Arasasingham P, Gluchowski C, Wong H, Burke J, et al. Analogs of UK 14,304: Structural features responsible for α2 adrenoceptor activity. Bioorganic Med Chem Lett. 1995;5(15):1745–50.

    Article  CAS  Google Scholar 

  20. Alphagan product leaflet. Allergan New Zealand Ltd: Allergan, Inc 2009.

  21. Gilhotra RM, Gilhotra N, Mishra DN. Piroxicam bioadhesive ocular inserts: physicochemical characterization and evaluation in prostaglandin-induced inflammation. Curr Eye Res. 2009;34(12):1065–73.

    Article  PubMed  CAS  Google Scholar 

  22. El-Gendy NA, Abdelbary GA, El-Komy MH, Saafan AE. Design and evaluation of a bioadhesive patch for topical delivery of gentamicin sulphate. Curr Drug Deliv. 2009;6(1):50–7.

    Article  PubMed  CAS  Google Scholar 

  23. Juliano C, Cossu M, Pigozzi P, Rassu G, Giunchedi P. Preparation, in vitro characterization and preliminary in vivo evaluation of buccal polymeric films containing chlorhexidine. AAPS PharmSciTech. 2008;9(4):1153–8.

    Article  PubMed  CAS  Google Scholar 

  24. U.S. Department of Health and Human Services. Guidance for industry: dissolution testing of immediate release solid oral dosage forms. Food and Drug Administration Center for Drug Evaluation and Research (CDER) 1997.

  25. Chandak AR, Verma PRP. Development and evaluation of HPMC based matrices for transdermal patches of Tramadol. Clin Res Regul Aff. 2010;6:1370–9.

    Google Scholar 

  26. Jain D, Carvalho E, Banerjee R. Biodegradable hybrid polymeric membranes for ocular drug delivery. Acta Biomater. 2010;6(4):1370–9.

    Article  PubMed  CAS  Google Scholar 

  27. Bialer M, Yacobi A, Moros D, Levitt B, Houle JM. Criteria to assess in vivo performance and bioequivalence of generic controlled-release formulations of carbamazepine. Epilepsia. 1998;39:513–9.

    Article  PubMed  CAS  Google Scholar 

  28. Panomsuk SP, Hatanaka T, Aiba T, Katayama K, Koizumi T. A study of the hydrophilic cellulose matrix: effect of drugs on swelling properties. Chem Pharm Bull. 1996;44:1039–42.

    CAS  Google Scholar 

  29. Eouani C, Piccerelle P, Prinderre P, Bourret E, Joachim J. In-vitro comparative study of buccal mucoadhesive performance of different polymeric films. Eur J Pharm Biopharm. 2001;52(1):45–55.

    Article  PubMed  CAS  Google Scholar 

  30. Alanazi FK, Abdel Rahman AA, Mahrous GM, Alsarra IA. Formulation and physicochemical characterization of buccoadhesive films containing ketorolac. J Drug Del Sci. 2007;17(3):183–92.

    CAS  Google Scholar 

  31. Cafaggi S, Leardi R, Parodi B, Caviglioli G, Russo E, Bignardi G. Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery. J Control Release. 2005;102(1):159–69.

    Article  PubMed  CAS  Google Scholar 

  32. Joshi HN, Wilson TD. Calorimetric studies of dissolution of hydroxypropyl methylcellulose E5 (HPMC E5) in water. J Pharm Sci. 1993;82(10):1033–8.

    Article  PubMed  CAS  Google Scholar 

  33. Hamza Yel S, Aburahma MH. Design and in vitro evaluation of novel sustained-release double-layer tablets of lornoxicam: utility of cyclodextrin and xanthan gum combination. AAPS PharmSciTech. 2009;10(4):1357–67.

    Article  Google Scholar 

  34. Singh KH, Shinde UA. Development and Evaluation of Novel Polymeric Nanoparticles of Brimonidine Tartrate. Curr Drug Deliv 2011; (in press).

  35. Patel RP, Patel MM. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30. Pharm Dev Technol. 2007;12(1):21–33.

    Article  PubMed  CAS  Google Scholar 

  36. Xiao C, Lu Y, Liu H, Zhang L. Preparation and physical properties of blend films from sodium alginate and polyacrylamide solutions. Macromol Sci Pure Appl Chem. 2000;A37(12):1663–75.

    Article  CAS  Google Scholar 

  37. Çaykara T, Demirci S, Kantoğlu Ö. Thermal, spectroscopic, and mechanical properties of blend films of poly(N–vinyl-2-pyrrolidone) and sodium alginate. Polymer Plast Tech Eng. 2007;46(7):737–41.

    Article  Google Scholar 

  38. Phromsopha T, Baimark Y. Methoxy poly(ethylene glycol)-b-poly(d, l-lactide) films for controlled release of ibuprofen. Trends Appl Sci Res. 2009;4:107–15.

    Article  CAS  Google Scholar 

  39. Elmotasem H. Chitosan–alginate blend films for the transdermal delivery of meloxicam. Asian J Pharm Sci. 2008;3(1):12–29.

    CAS  Google Scholar 

  40. Badr-Eldin SM, Elkheshen SA, Ghorab MM. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Eur J Pharm Biopharm. 2008;70(3):819–27.

    Article  PubMed  CAS  Google Scholar 

  41. Ruan LP, Yu BY, Fu GM, Zhu DN. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J Pharm Biomed Anal. 2005;38(3):457–64.

    Article  PubMed  CAS  Google Scholar 

  42. Redenti E, Peveri T, Zanol M, Ventura P, Gnappi G, Montenero A. A study on the differentiation between amorphous piroxicam:β-cyclodextrin complex and a mixture of the two amorphous components. Int J Pharm. 1996;129:289–94.

    Article  CAS  Google Scholar 

  43. Kaur IP, Smitha R. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm. 2002;28(4):353–69.

    Article  PubMed  CAS  Google Scholar 

  44. Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. 2005;57(11):1595–639.

    Article  PubMed  CAS  Google Scholar 

  45. Sasaki H, Nagano T, Sakanaka K, Kawakami S, Nishida K, Nakamura J, et al. One-side-coated insert as a unique ophthalmic drug delivery system. J Control Release. 2003;92(3):241–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Declaration of Interest

The authors report no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt

    Mona Hassan Aburahma

  2. Department of Pharmaceutical Technology, National Research Center, Tahreer St., Dokki, Cairo, Egypt

    Azza Ahmed Mahmoud

Authors
  1. Mona Hassan Aburahma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Azza Ahmed Mahmoud
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Azza Ahmed Mahmoud.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aburahma, M.H., Mahmoud, A.A. Biodegradable Ocular Inserts for Sustained Delivery of Brimonidine Tartarate: Preparation and In Vitro/In Vivo Evaluation. AAPS PharmSciTech 12, 1335–1347 (2011). https://doi.org/10.1208/s12249-011-9701-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-011-9701-3

Key words

Search

Navigation